The 17th Annual Meeting of the Chinese Society of Surgeons (CCS2024) wrapped up!

On July 11-14 2024, the 17th Annual Meeting of Surgeons of the Chinese Physicians Association (CCS2024) was successfully held in Shanghai. The event was sponsored by the Chinese Medical Doctor Association and the Chinese College of Surgeons, and hosted by Zhongshan Hospital of Fudan University

Spectacular Coference Content

The Congress has arranged 40 sessions to promote academic exchanges, focus on cutting-edge knowledge in the international surgical field, and integrate theory and practice to enhance the comprehensive ability of medical workers, improve the level of clinical practice, and promote the development and progress of surgery. Over 700 domestic well-known experts and scholars participated, bringing cutting-edge medical knowledge and practical experience to the participants through nearly 80 spectacular lectures.

Bluesail Surgical Generate buzz

This conference attracted numerous famous enterprises, and Bluesail Surgical proudly showcased its exceptional and innovative instruments to the audience. Despite being a newcomer to the surgical instruments market, Bluesail Surgical has quickly established a stellar industry reputation, drawing a continuous stream of visitors to its exhibit.

Bluesail Surgical unveiled its pioneering and original surgical instrument products, the RenoVue® & RenoPort® Novel Intra-Abdominal Lens Cleaning Device, at the exhibition. The device impressed with its exceptional and efficient cleaning capabilities, particularly beneficial for prolonged surgeries. It significantly reduces the time and effort required for lens cleaning while ensuring the safety and seamless progression of surgeries. Professionals at the event unanimously praised its closed-loop cleaning technology, pulsed air-ballistic flow technology, non-sensory switch, and other breakthrough design features.

Mr. Zhong Shuqiao, CEO of Bluesail Medical, personally visited the booth to guide and introduce the company's culture to the visiting experts. He strongly emphasized that under the current situation of rapid development of medical instruments in China, Bluesail Surgical remains committed to the spirit of craftsmanship, as a newcomer in surgical devices, the company not only provides high-quality traditional surgical medical devices but also maintains a spirit of innovation, continuously delivering new and more convenient products to the market.

In addition, the other series of Bluesail Surgical products have garnered significant attention. The Siderlux™ Intelligent Powered Endo Stapler has excellent stapler formation, its thick tissue cutting feel and electric strike function effectively reduce jaw shakes and enhance surgical safety. The Astrolux™ Intelligent Powered Endo Stapler features built-in chips that enable intelligent firing, pressing, recognition, and human-computer interaction, complemented by the spy-beak accessory for enhanced clinical safety.

The TisFree® Ultrasonic Scaple System adeptly closes 5mm blood vessels, utilizing precise algorithms and efficient control to strike the perfect balance between cutting and coagulation, resulting in superior vascular closure. This ultrasonic soft tissue cutting and hemostatic device sets new standards for safety and precision in vessel closure.

Bluesail Surgical staff introduced its wide range of products to on-site professionals, attracting many participants to stop and watch. Many of them highly appreciated Bluesail Surgical's full product line.

Summary of Meeting

The company's clear strategy, exceptional organizational skills, and commitment to original design and independent mass production have resulted in the development of core surgical products like the RenoVue® & RenoPort® Novel Intra-Abdominal Lens Cleaning Device, Siderlux™ and Astrolux™ Intelligent Powered Endo Stapler, and TisFree® Ultrasonic Scaple System.

Specializing in mainstream surgical procedures, Bluesail Surgical is fully dedicated to becoming the leading national surgical instruments brand. It is anticipated that Bluesail Medical will soon lead the industry and become the standard for the development of China's domestic surgical instruments.